1. Morbidity of the Whole Population of Russia in 2014. Statistical Data from the Ministry of Health of the Russian Federation, https:/
www.rosminzdrav.ru/documents/9479-statisticheskaya-informatsiyaza-2014
, acc. June 15, 2016.
2. E. I. Gusev, I. A. Zavalishin, and A. N. Boiko (eds.), Multiple Sclerosis. Clinical Guidelines, Real Time, Moscow (2011).
3. Approval package for application number: NDA 20-622/S-015. Center for Drug Evaluation and Research FDA, July 12, 2001, www. accessdata.
fda.gov/drugsatfda_docs/nda/2001/020622_S015_COPAXONE_INJECTION_AP.pdf
, acc. June 15, 2016.
4. Copaxone (glatiramer acetate for injection). New Drug Application for FDA NDA 20-622/S-015/S-015. 2001,
www.accessdata.fda.gov/drugsatfda_docs/label/2001/20622s15lbl.pdf
, acc. June 15, 2016.